Huntleigh Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Huntleigh Advisors, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $16.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$16.1M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 11,626 | $4.1M |
| LLYELI LILLY & Co | 2,877 | $2.6M |
| ABBVAbbVie Inc. | 10,915 | $2.4M |
| PFEPFIZER INC | 65,227 | $1.8M |
| ADPTAdaptive Biotechnologies Corp | 89,094 | $1.2M |
| ASRTAssertio Holdings, Inc. | 52,603 | $1.0M |
| ABTABBOTT LABORATORIES | 7,126 | $732K |
| JNJJOHNSON & JOHNSON | 2,351 | $575K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,033 | $550K |
| MRKMerck & Co., Inc. | 3,958 | $476K |
| PMPhilip Morris International Inc | 2,589 | $428K |
| VTRSViatris Inc | 13,806 | $187K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.